Synta Announces Clinical Program Updates and 2010 Financial Results. Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported fourth-quarter and full-year 2010 financial results, provided an update on recent progress with its programs, and announced 2011 objectives.
read story
www.businesswire.com/news/home/20110311005403/en/Synta-Announces-Clinical-Program-Updates-2010-Financial
No comments:
Post a Comment